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Besanqon and Griffon,  1 Chickering, 2 Blake,  3 and others have shown 
that  agglutinins  appear  in  the  blood  of  lobar  pneumonia  patients 
during the course of the disease or during convalescence.  In Blake's 
series, agglutinins  for the homologous pneumococcus appeared in the 
blood  in  all  patients  who  recovered,  just  before,  during,  or  after 
crisis or lysis.  Their  concentration  increased  rapidly  at  the  time 
of recovery and remained elevated during convalescence in the milder 
cases  and  showed  a  tendency  to  fall  off in  the  more  severe  cases. 
Reference to his charts shows that in one case the amount of agglu- 
tinin,  as measured  by the highest  dilution  in  which  a  positive  test 
occurred, reached such a concentration that the homologous organism 
was  agglutinated  by a  dilution  of  1:32  of  the  patient's  serum and 
that in two other cases it reached 1 : 16.  Fatal cases failed to develop 
demonstrable agglutinins  in the blood. 
Cole  4 has noted that empyema fluids due to pneumococcus infection 
contain large amounts of soluble substances which have the property 
of  neutralizing  pneumococcus  antibodies.  For  the  purpose  of  his 
investigation,  as indicated by the protocol of one of his experiments, 
0.4 cc. of  empyema fluid  due to  Type I  pneumococcus,  cleared  by 
contrifuging, and mixed with an equal volume of an  increasing  dilu- 
tion  of  antipneumococcus  serum,  was  tested for  its power to cause 
agglutination of Type I pneumococcus.  The admixture of pneumonic 
t Besangon, F., and Griffon, V., Compt. rend. Soc. biol., 1897, xlix, 551,579. 
Chickering, tI. T., ]. Exp. Med., 1914, xx, 599. 
3 Blake, F. G., Arch. Int. Med., 1918, xxi, 779. 
4  Cole, R., ]. Exp. Med., 1917, xxvi, 453. 
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fluid  with  the  homologous  antipneumococcus  serum  in  our  hands 
always gave rise  to a  precipitate  which we have  had  to  remove by 
the centrifuge. 
Agglutinins  in  Pneumonic  Lung  Exudate.--In  order  to  determine 
to what degree specific agglutinins for the homologous organism may 
be  present  in  the  pneumonic  lung,  the  following  experiment  was 
performed with the macroscopic method. 
The lung mash from a  case of Type I  pneumonia was centrifuged 
and  increasing  dilutions  of  the  supernatant  fluid  were  transferred 
to small test-tubes, each containing  5 drops of a  suspension of Type 
I  pneumococcus,  as  shown  in  Table  I.  After  2  hours  incubation 
agglutination was noted in a  dilution of 1 : 2 of the exudate, question- 
able agglutination  at  1 : 10, and  none  at  1 : 20.  A  control series con- 
TABLE  I. 
Tests for Agglutinins in Type I  Pneumococcic Exudate. 
Tube No. 
Suspension  of 
Pneumocoecus 
Type I. 
g~t. 
5 
5 
5 
Lung exudate. 
Amount.  Dilution. 
glt. 
5  Undiluted. 
5  1:5 
5  1:10 
Final dilution 
of 
lung exudate. 
1:2 
1:10 
1:20 
Agglutination.* 
+ 
? 
0 
* Observation after incubation for 2 hours and in ice box over night. 
taining  the  same  strain  of  Type  I  pneumococcus  and  homologous 
antipneumococcus  horse  serum  showed  agglutination  in  a  dilution 
as high as 1:80 of the serum. 
The lung mash from a  second case of fatal Type I  lobar pneumonia 
was similarly tested.  The clear fluid was mixed in increasing dilution 
with  normal  saline  solution.  To  each  tube were  added  2  drops  of 
a  suspension  of Type  I  pneumococcus.  No  agglutination  of  the 
organisms was noted at any dilution, the lowest being 1 : 4 of the lung 
fluid.  Antipneumococcus horse serum  agglutinated  the  same strain 
in as high a  dilution as 1:40 of the serum. 
In  a  case of Type III  pneumonia  no  agglutination  was observed 
at  any  dilution,  the  strongest  used  being  1:2  of  the exudate.  In 
tests  simultaneously  performed  Type  III  antipneumococcus  horse FREDERICK  T.  LORD  AND  ROBERT  N.  NYE 
TABLE  II. 
Agglutination  Titer with Normal Saline Solution. 
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Tube  No.  Serum dilution.  Agglutination. 
1:10 
1:20 
1:40 
1:80 
1:160 
1:320 
+ 
++ 
++++ 
++ 
+ 
0 
0.S cc, of increasing dilutions of Type III antipneumococcus serum  +  0.5  cc. 
of normal saline solution +  3 drops of Type III pneumococcus suspension. 
TABLE  17/. 
Aggtutination  Titer with Normal Saline  Solution  and Chloroform. 
Tube No.  Serum dilution.  Agglutination. 
1:10 
1:20 
1:40 
1:80 
1:160 
1:320 
+ 
++ 
+++ 
++ 
0 
0 
0.S cc. of increasing dilutions of Type III antipneumococcus serum +  0.5 cc. 
of  normal  saline  solution  +  3  drops of  chloroform  -[- 3  drops of  Type  III 
pneumococcus. 
TABLE  IV. 
Agglutination  Titer with Normal Sabine Solution  and  Toluene. 
Tube No.  Serum dilution.  Agglutination. 
1:10 
1:20 
1:40 
1:80 
1:160 
+ 
++ 
++++ 
+ 
0 
0.5 cc. of increasing dilutions of Type III antipneumococcus serum +  0.5 cc. 
of normal saline solution +  0.5  cc.  of toluene +  3  drops of Type III pneumo- 
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serum agglutinated the  same strain  of pneumococcus in  a  dilution 
as high as 1:40 of the serum. 
To  exclude the possibility  that  the method of preservation with 
toluene and chloroform might influence the result, the agglutination 
titer of Type III  antipneumccoccus serum against  the  homologous 
organism was determined and found not to  vary more than  might 
be expected from some slight but indeterminable added dilution of 
the serum when the serum was mixed with (1)  normal saline solution 
(Table II),  (2)  saline solution and chloroform (Table III),  (3) saline 
solution and toluene (Table IV), and  (4)  saline solution, chloroform, 
and toluene (Table V). 
TABLE  V. 
Agglutination Titer with Normal Saline Solution, Toluene, and Chloroform. 
Tube No.  Serum dilution.  Agglutination. 
1:10 
1:20 
1:40 
1:80 
1:160 
++++ 
++++ 
++++ 
0 
0 
0.5 cc. of increasing dilutions of Type III antipneumococcus  serum +  0.5 cc. of 
normal saline solution +  0.5 cc. of toluene +  3 drops of chloroform +  3 drops of 
Type III pneumococcus. 
Our previous experiments indicate that there are only very small 
amounts of, or no agglutinins for the homologous pneumococcus in the 
pneumonic  exudate,  although  it  is  still  possible  that  agglutinins 
may be present and undemonstrable in consequence of neutralization 
by the large amount of dissolved bacterial  extract in  the exudate. 
There  is,  in  fact,  evidence  that  when  antipneumococcus serum  is 
mixed with  the homologous  exudate a  considerable amount  of ag- 
glutinin is removed from the serum, as indicated by the experiment 
illustrated in Table VI. 
In a series of tubes numbered A1, B1, and C1, after mixing varying 
dilutions of homoiogous antipneumococcus serum and Type I  pneu- 
monic exudate diluted with an equal volume of saline solution,  the 
resulting precipitate was  removed by means of the centrifuge.  10 FREDERICK T.  LORD  AND  ROBERT  N.  NYE  215 
drops  of  the  clear  supernatant  fluid were  then  removed from  each 
tube  to fresh tubes  and  to each 2  drops  of a  suspension  of Type I 
pneumococcus were added.  As indicated in Table VI agglutination 
occurred only in Tube A1 which contained a  dilution of 1 : 2  of serum 
and  1:4 of pneumonic fluid. 
When,  however,  to  a  second  set  of  tubes  numbered  As,  Bs,  and 
C2, containing 0.4 cc. of increasing dilutions of the same lot of Type 
TABLE VI. 
Removal of Agglutinin from Anlipneumococcic  Serum by Homologous Pneumococcus 
Exudate. 
I 
Tube  I 
No.  ! 
I 
A1 
BI 
CI 
A2 
B, 
Cs 
A3 
B8 
Cs 
=o 
G¢. 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
Type I serum. 
Dilution. 
Normal 
saline 
solu- 
tion. 
Pneumonic fluid q- equal 
volume of 
normal saline solution. 
Dilution. 
L 
Final dilution. 
I  ~uspen-  sion of 
Pneumo- 
Pneu- ~  cocci 
Serum.  monie I  Type L 
i 
Undiluted. 
1:10 
1:20 
1:10 
1:20 
1:40 
I 
I 
~.  C~. 
0.4 
0.4 
0.4 
0.4 
i  0.4 
i  0.4 
i 
0.4  0.4 
0.4  0.4 
0.4  0.4 
Undiluted.t 
"  t 
Undiluted. 
1:10 
1:20 
fluid.  ] 
i 
1:2  1:4  I 
1:20  1:4 
1:40  1:4 
I 
1:20 
1:40  I 
1:80  I 
1:4 
i:40 
1:80 
g/t. 
2 
2 
2 
= 
< 
+ 
0 
0 
÷ 
+ 
0 
0 
0 
0 
* The plus signs indicate the presence of agglutination, without regard to its 
degree. 
t Centrifuged to remove precipitate. 
I  antipneumococcus  serum  and  prepared  at  the  same  time,  0.4  cc. 
of normal saline solution were added in place of the pneumonic  exu- 
date and  2  drops of  the same  suspension of  Type I  pneumococcus, 
agglutination  took  place  in  as  high  a  dilution  as  1:20  and  1:40 
of  the  serum.  There  are,  therefore,  substances  in  the  exudate 
which  inhibit  agglutination  or  the  agglutinins  are  removed  by  the 
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As a control, in Tubes A,, B~, and C3, 2 drops of the same suspen- 
sion  of  Type  I  pneumococcus were  added  to  increasing  dilutions 
of the pneumonic fluid plus an equal volume of normal saline solu- 
tion.  No  agglutination  took  place  at  any  dilution,  the  highest 
strength of the pneumonic fluid used being 1 : 4.  The agglutination 
of  the  organisms  in  the  mixture  of  antipneumococcus serum  and 
pneumonic exudate  (Tube A1)  is in  consequence to  be  ascribed  to 
the  agglutinins in  the  serum  rather  than  any  in  the  pneumonlc 
exudate. 
CONCLUSIONS. 
Specific agglutinins for the homologous pneumococcus are lacking 
or present only in small amount in the pneumonic exudates due to 
the fixed types of pneumococci.  Suspensions of fixed types of pneu- 
mococci in the supernatant fluid obtained after centrifuging the mash 
of the pneumonic lung give positive agglutination tests in dilutions 
not  higher  than  equal  parts  of  suspension  and  supernatant  fluid 
(1:2).  The pneumonic lung contains a soluble substance inhibiting 
agglutination of the fixed types of pneumococci by the homologous 
antipneumococcus serum. 